Pharma Corina Croitoru of Gedeon Richter Slovakia discusses GR’s footprint in the country, the affiliate’s main growth drivers, the importance of women’s health, and the intricacies of market access. Gedeon Richter’s affiliate in Slovakia was established back in 1996 and you yourself have been country manager for the past couple of…
Pfizer Slovakia’s Country Manager and Lead Internal Medicine / Pfizer Innovative Health Branislav Budke discusses the success of Pfizer in Slovakia, the challenges of the healthcare system, and political changes that can potentially contribute towards the easier market access of innovative treatments, due to his dual role as Head of…
The following chart shows the top five pharma companies in the Czech market, ranked by both value and volume. Novartis leads the way in terms of value, but Sanofi is far ahead in terms of volume with almost 20% market share. Click here to read more articles and interviews from…
Healthcare The benefits of economic growth in the Philippines are slowly starting to trickle down to the poorest in society via a more inclusive and affordable healthcare system. Access to healthcare information is also improving, allowing Filipinos to better understand their health. “Better informed patients make better patients.” Noel Lantin, Medicomm Pacific You…
Biologics giant Biogen is investing USD one billion in a next-generation manufacturing facility in Luterbach, near Solothurn, Switzerland, tripling production capacity and creating 400 new jobs. The decision to situate the new capabilities outside of North America reflects an eagerness to attain a greater level of diversity across our production…
Pharma MD Natascha Schill discusses the growing importance and commitment that Biogen has to Switzerland, including a USD one billion investment in new facilities and the creation of 400 jobs in the upcoming years; investing in the local workforce to support the company’s growth. The headline-making news at the moment is…
Ireland Dr. Paul Downing, General Manager of Hovione’s manufacturing plant in Cork, outlines the successes of the past few years, his emphasis on staff development and training, the CDMO’s advantages of agility and responsiveness, Ireland’s value proposition for the pharma manufacturing industry, and his vision for the next few years. Can…
Ireland Alan MacNeice, Executive Director and Site Leader at Jazz Pharmaceuticals, highlights the strategic importance of the Athlone site as the company’s first purpose-built, directly owned, managed and operated manufacturing facility; the special design of the facility catering to Jazz Pharmaceuticals business model; the importance of their human resource (HR) activities…
Ireland Noel Heaney, general manager of BMS Biologics Ireland, provides an overview of BMS in Ireland, its exciting new USD 900 million biologics facility in Cruiserath, their innovative HR programs and his five-year-vision for BMS Biologics in Ireland. BMS has a strong heritage in Ireland dating back to 1964 when it…
Philippines Beaver Tamesis, Managing Director at MSD Philippines, discusses the company’s impressive growth in recent years as well as their expanding portfolio. Additionally, he discusses his work to foster engagement and motivation throughout the MSD affiliate in the country. When we first met you in 2013 you were only a few…
Ireland As a major innovative hub for (bio)pharma innovation, Ireland should be a place where innovative medicines are adopted quickly within the local healthcare system. IPHA director Oliver O’Connor explains the significance of the new 2016 IPHA agreement in contributing to a sustainable Irish healthcare budget and the delivery of innovative…
Health Pascal Strupler of the Federal Office of Public Health discusses the intricacies of the Swiss healthcare system, highlighting the importance of the NCD in health prevention, strategies for cost reduction, and his support for open dialogue between healthcare stakeholders in order to provide the public with an accessible and efficient…
See our Cookie Privacy Policy Here